Clinical Trials

Adenocarcinoma, Prostatic Neoplasms

NCT06616597 2026-02-19

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

58 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07417475 2026-02-18

Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction

Phase NA Completed

200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07115914 2026-02-17

PSMA PET for Surveillance After Focal Therapy

62 enrolled

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT07413120 2026-02-17

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

Phase 3 Completed

40 enrolled

Adenocarcinoma, Kidney Neoplasms, Prostatic Neoplasms

NCT07196488 2026-02-09

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

60 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06631521 2026-02-05

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Phase 1 Recruiting

30 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07363382 2026-01-23

The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

Phase 1/2 Recruiting

6 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07344844 2026-01-15

SPAR

Adenocarcinoma, Prostatic Neoplasms

NCT06592924 2026-01-14

TRIPLE-SWITCH

Phase 3 Recruiting

830 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07339943 2026-01-14

MicroUSgFLA

7 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07129551 2026-01-12

NICE-PSMA

102 enrolled

Phase 2 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07302451 2026-01-06

REDI-CaP

50 enrolled

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07316686 2026-01-05

Lutécio

18 enrolled

Phase 2 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT00756639 2025-12-17

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

31 enrolled

CNSGenitourinary

Adenocarcinoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell

NCT07268794 2025-12-08

CONVERT-HB1

Phase 2 Not yet recruiting

112 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

3,000 enrolled

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT06844383 2025-10-29

TALENT

126 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07219303 2025-10-29

DE-CART

80 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Prostatic Neoplasms

NCT07218003 2025-10-24

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Recruiting

149 enrolled

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06800313 2025-10-16

A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 1/2 Recruiting

33 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07209878 2025-10-07

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

Phase 2/3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07179783 2025-09-18

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

28 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04545957 2025-07-28

JUMP

GastrointestinalGenitourinaryHead & Neck

86 enrolled

Adenocarcinoma, Head and Neck Neoplasms, Liver Neoplasms, Prostatic Neoplasms

NCT05574647 2025-07-24

IP7-PACIFIC

3,600 enrolled

Adenocarcinoma, Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT07038304 2025-06-26

OLYMPIAN

35 enrolled

Phase 1 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT00911118 2025-06-03

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

120 enrolled

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06931496 2025-04-17

PROSTIA- BP

150 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06926374 2025-04-16

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

GastrointestinalGenitourinarySarcoma

90 enrolled

Adenocarcinoma, Urinary Bladder Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Rectal Prolapse, Stomach Neoplasms, Colorectal Neoplasms, Gallstones, Gastrointestinal Stromal Tumors

NCT04556617 2025-04-08

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 1/2 Terminated

19 enrolled 11 charts

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06915909 2025-04-08

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

40 enrolled

Phase 3 Not yet recruiting

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

NCT06855589 2025-03-04

PCS-XII

400 enrolled

Phase NA Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06844513 2025-02-25

URO-ROBOT-2023

800 enrolled

Adenocarcinoma, Kidney Neoplasms, Prostatic Neoplasms

NCT06822036 2025-02-17

ARISTA

362 enrolled

Phase 1 Active not recruiting

Adenocarcinoma, Hemorrhage, Prostatic Neoplasms, Postoperative Hemorrhage

NCT04660929 2024-12-18

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

48 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT05128487 2024-11-25

A Study of NDI 1150-101 in Patients With Solid Tumors

Phase 1/2 Active not recruiting

106 enrolled

GenitourinaryThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT06665932 2024-11-12

Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

Adenocarcinoma, Prostatic Neoplasms

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Adenocarcinoma, Prostatic Neoplasms

NCT05328505 2024-09-26

MIDAS-Prostate

80 enrolled

Phase EARLY_PHASE1 Recruiting

Adenocarcinoma, Prostatic Neoplasms, Recurrence

NCT06612580 2024-09-25

68Ga-AAZTA-NI-093 PET/CT: First-in-human Study

10 enrolled